$100,000 of NOVAVAX INC lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Issues related to COVID-19 vaccines ...
Shares of Novavax Inc. NVAX slid 3.46% to $9.22 Friday, on what proved to be an all-around rough trading session for the ...
CureVac is developing this investigational mRNA-based vaccine in collaboration with GSK. Novavax NVAX is also developing a bird flu vaccine in preclinical studies. NVAX claimed that this vaccine ...
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced progress in Q4 2024 advancing its corporate growth strategy through ...
2d
Capstone Companies, Inc. (OTCQB: CAPC) announced today the appointment of Brian Rosen as a non-employee director, effective January 20, 2025.
GitLab Inc. (NASDAQ:GTLB) is a leading DevOps platform ... Novavax, Inc. (NYSE:NVAX) is a leading biotechnology company dedicated to the discovery, development, and commercialization of innovative ...
But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant ...
But the company trimmed its outlook. Is NVAX stock a sell in December 2024? Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Investing in under-the-radar stocks can be a savvy move for those looking to diversify their portfolios and potentially reap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback